NCCN 2010: Dr. Lee Krug, Memorial Sloan-Kettering Cancer Center

Article

Lee M. Krug, MD of the Memorial Sloan-Kettering Cancer Center speaks about New NCCN Guidelines for Mesothelioma at the 15th Annual NCCN Conference in Hollywood, FL March, 2010.

Recent Videos
Arshad Khanani, MD: Four-Year Outcomes of Faricimab for DME in RHONE-X | Image Credit: Sierra Eye Associates
Dilraj Grewal, MD: Development of MNV in Eyes with Geographic Atrophy in GATHER | Image Credit: Duke Eye Center
Margaret Chang, MD: Two-Year Outcomes of the PDS for Diabetic Retinopathy | Image Credit: Retina Consultants Medical Group
Carl C. Awh, MD: | Image Credit:
Raj K. Maturi, MD: 4D-150 for nAMD in PRISM Population Extension Cohort | Image Credit: Retina Partners Midwest
Charles C. Wykoff, MD, PhD: Interim Analysis on Ixo-Vec Gene Therapy for nAMD | Image Credit: Retina Consultants of Texas
Sunir J. Garg, MD: Pegcetacoplan Preserves Visual Function on Microperimetry | Image Credit: Wills Eye Hospital
Edward H. Wood, MD: Pharmacodynamics of Subretinal RGX-314 for Wet AMD | Image Credit: Austin Retina Associates
Dilsher Dhoot, MD: OTX-TKI for NPDR in Interim Phase 1 HELIOS Results | Image Credit: LinkedIn
Katherine Talcott, MD: Baseline EZ Integrity Features Predict GA Progression | Image Credit: LinkedIn
Related Content
Semaglutide May Reduce Rates of Diabetic Retinopathy Outcomes | Image Credit: Twitter

Semaglutide May Reduce Rates of Diabetic Retinopathy Outcomes

Connor Iapoce
July 24th 2024
Article
Diabetes Dialogue: ADA 2024 Diabetes Technology Recap

Diabetes Dialogue: ADA 2024 Diabetes Technology Recap

Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES;Natalie Bellini, DNP, FNP-BC, BC-ADM, CDCE
July 3rd 2024
Podcast
Zafar Gill, MD | Credit: Childrens Hospital Colorado

Study Links Maternal Asthma to Blinding Eye Disease in Premature Infants

Patrick Campbell
July 22nd 2024
Article
Carol Levy, MD | Credit: T1D Exchange

Diabetes Dialogue: Patient Considerations for Inhaled Insulin, with Carol Levy, MD

Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES;Natalie Bellini, DNP, FNP-BC, BC-ADM, CDCE
June 30th 2024
Podcast
NEPTUNE: Oral Brepocitinib Effective in Non-infectious Uveitis at 24 Weeks

NEPTUNE: Oral Brepocitinib Effective in Non-infectious Uveitis at 24 Weeks

Connor Iapoce
July 20th 2024
Article
Arshad Khanani, MD | Credit: LinkedIn

RHONE-X: 90% of Patients Treated with Faricimab Free from DME at 4 Years

Patrick Campbell
July 19th 2024
Article
© 2024 MJH Life Sciences

All rights reserved.